4/10/26 16:05 | 4/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Van Tuyl Christopher | NC | O | GC | 3 | S | -491 | 26.04 | 0 | -19 | | 183 | D | | | | | | | | | | | | | | |
4/10/26 16:03 | 4/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Gloria Melanie | NC | O | COO | 3 | S | -605 | 24.61 | 0 | -25 | | 245 | D | | | | | | | | | | | | | | |
4/10/26 16:02 | 1/7/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NC | O | CTO | 9 | S | -566 | 21.89 | 0 | -26 | | 254 | D | | | | | | | | | | | | | | |
4/3/26 16:33 | 4/2/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 1 | S.d | -343 | 24.10 | 0 | -14 | | 20 | D | | | | | | | | | | | | | | |
12/3/25 18:14 | 12/1/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Fromkin Andrew J. | NY | D | | 2 | S | -674 | 22.28 | 0 | -30 | | 92 | D | | | | | | | | | | | | | | |
12/3/25 18:14 | 12/1/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Hughes Douglas J. | NY | D | | 2 | S | -503 | 24.65 | 0 | -20 | | 121 | D | | | | | | | | | | | | | | |
10/24/25 16:38 | 10/22/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Geffner Michael | NY | O | Chief Me | 6 | S | -231 | 18.59 | 0 | -12 | | 225 | D | | | | | | | | | | | | | | |
4/17/25 16:08 | 4/16/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Barnett Eva Renee | NY | O | CFO | 4 | S | -257 | 21.04 | 0 | -12 | | 397 | D | | | | | | | | | | | | | | |
4/17/25 16:07 | 4/16/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Salzmann Peter | NY | DO | CEO | 5 | S | -1,143 | 17.39 | 0 | -66 | | 1,187 | D | | | | | | | | | | | | | | |
2/21/25 16:06 | 2/19/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | 2 | S | -100 | 22.45 | 0 | -4 | | 359 | D | | | | | | | | | | | | | | |
12/4/24 16:22 | 12/2/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Pande Atul | NY | D | | 1 | S | -221 | 28.54 | 0 | -8 | | 107 | D | | | | | | | | | | | | | | |